Pmv Pharmaceuticals, Inc. · NASDAQ:PMVP
BML Investment Partners, L.P. reported a 9.90% stake in Pmv Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 9, 2026
BML Investment Partners, L.P. reported a 9.90% stake in Pmv Pharmaceuticals, Inc., 5,292,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 5,292,000
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BML Investment Partners, L.P. | 9.90% | 5,292,000 |
Source
Related
- Pmv Pharmaceuticals, Inc.
- Braden M Leonard
- Pmv Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Braden M Leonard · Feb 14, 2025
- Schedule 13G/A · Braden M Leonard · Feb 14, 2025
- Schedule 13G · Srinivas Akkaraju · Sep 15, 2026
- Schedule 13G/A · Sio Capital Management, LLC · Jul 28, 2026
- Schedule 13G/A · ArrowMark Colorado Holdings LLC · Jul 10, 2026
- Schedule 13G/A · Euclidean Capital LLC · May 15, 2026
- Schedule 13G/A · Sio Capital Management, LLC · May 4, 2026